Semrush insider plans Rule 144 sale of 196,116 common shares

Semrush Holdings reported that an insider has filed a Rule 144 notice to sell 196,116 shares of common stock.

Rhea-AI Filing Summary

Semrush Holdings reported that an insider has filed a Rule 144 notice to sell 196,116 shares of common stock. The planned sale, through Morgan Stanley Smith Barney LLC on the NYSE, has an aggregate market value of $2,322,907.78 based on the information provided. The issuer had 128,163,859 shares outstanding as of the filing data point. The shares to be sold were acquired through a stock option exercise on 12/08/2025 for 84,585 shares paid in cash and a restricted stock grant on 10/06/2022 for 111,531 shares. The person signing the notice represents that they are not aware of undisclosed material adverse information about the company.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Semrush (SEMR) shares are planned to be sold under this Rule 144 notice?

The notice covers the planned sale of 196,116 shares of Semrush common stock.

What is the aggregate market value of the Semrush (SEMR) shares in this planned Rule 144 sale?

The planned sale has an aggregate market value of $2,322,907.78 based on the figures in the notice.

How many Semrush (SEMR) shares were outstanding at the time referenced in the notice?

The notice states that 128,163,859 shares of Semrush common stock were outstanding at the referenced time.

How were the Semrush (SEMR) shares being sold under Rule 144 acquired?

Of the shares to be sold, 84,585 were acquired via a stock option exercise on 12/08/2025 for cash, and 111,531 were acquired as restricted stock on 10/06/2022.

Which broker is handling the planned Rule 144 sale of Semrush (SEMR) shares?

The notice lists Morgan Stanley Smith Barney LLC Executive Financial Services as the broker, with the sale to take place on the NYSE.

What representation does the insider make in this Semrush (SEMR) Rule 144 notice?

By signing, the person for whose account the securities are to be sold represents that they do not know of any material adverse information about Semrush’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/08/2025 - 06:47 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001884375
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SEMRUSH HOLDINGS, INC.
SEC File Number	001-40276
Address of Issuer	800 BOYLSTON STREET, SUITE 2475 BOSTON MASSACHUSETTS 02199
Phone	800-851-9959
Name of Person for Whose Account the Securities are To Be Sold	ANDREW WARDEN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	196116	2322907.78	128163859	12/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/08/2025	Stock Option Exercise	Issuer			84585	12/08/2025	Cash
Common	10/06/2022	Restricted Stock	Issuer			111531	10/06/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the vesting of restricted stock during the period of 10/06/2022 through 12/01/2025.
Date of Notice	12/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Andrew Warden
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)